HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
suritozole
Also Known As:
2,4-dimethyl-5-(3-fluorophenyl)-3H-1,2,4-triazole-3-thione; MDL 26,479; MDL 26479; MDL-26479
Networked:
2
relevant articles (
1
outcomes,
0
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Azoles: 2138
Triazoles: 1533
suritozole: 2
Related Diseases
1.
Traumatic Brain Injuries (Traumatic Brain Injury)
11/01/1995 - "
Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury.
"
11/01/1995 - "
The present experiment examined the efficacy of postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor that enhances cholinergic function, in attenuating spatial memory deficits after traumatic brain injury in the rat.
"
2.
Cognitive Dysfunction
11/01/1995 - "
Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury.
"
3.
Memory Disorders (Memory Loss)
05/01/1997 - "
MDL 26479 is a new drug undergoing clinical evaluation for the treatment of depression and for memory loss associated with Alzheimer's disease.
"
4.
Alzheimer Disease (Alzheimer's Disease)
05/01/1997 - "
MDL 26479 is a new drug undergoing clinical evaluation for the treatment of depression and for memory loss associated with Alzheimer's disease.
"
Related Drugs and Biologics
1.
suritozole
2.
Cholinergic Agents (Cholinergics)